Skip to main navigation Skip to search Skip to main content

Risk associated with bilobectomy after neoadjuvant concurrent chemoradiotherapy for Stage IIIA-N2 non-small-cell lung cancer

  • Korea University
  • Sungkyunkwan University

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Risk associated with bilobectomy after neoadjuvant concurrent chemoradiotherapy for Stage IIIA-N2 non-small-cell lung cancer'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry